See our Locations
We offer career development opportunities in over 170 locations across the world. Explore some of our featured locations.
Search
FIBRONEER™ trials for IPF, other progressive fibrosing ILDs
Donald Zoz, M.D., Director and Senior Clinical Program Leader for Pulmonary Fibrosis, discusses the FIBRONEER™ global clinical program
Human Health
Human Health
Boehringer’s unique approach to innovation
Boehringer’s unique approach to driving patient-centric innovation
Disentangling Fibrosis: Finding ways to fix ‘repair gone wrong’
Disentangling Fibrosis: Finding ways to fix ‘repair gone wrong’
Our Partners: ViraTherapeutics
Our Partners: ViraTherapeutics
A Unique Bond: human and animal health
A Unique Bond: human and animal health
Human Health Innovation
Pipeline
Companion Animals & Horses
Companion Animals & Horses
Our Innovation Prize | Partnering
Established in 2015 and jointly sponsored by BI and the BI Venture Fund, the prize allows recipients to focus on development of breakthrough medicines.
Partnering Days
Partnering Days
Biopharma Contract Manufacturing
Biopharma Contract Manufacturing
Across Cancer Types
Across Cancer Types
Swine
Swine
Tackling Health Disparities and Inequities for Women With Heart Failure: New Program Encourages Black and Latina Women to Demand More From Their Care
Tackling Health Disparities and Inequities for Women with Heart Failure: New Program Encourages Black and Latina Women to Demand More From Their Care
Oncology & Cancer Immunology
Oncology & Cancer Immunology
Oncology & Cancer Immunology
Oncology & Cancer Immunology
Lung Cancer
Lung Cancer
Respiratory
Respiratory
How Simulation is Changing the Game in Biotherapeutic Drug Development
How Simulation is Changing the Game in Biotherapeutic Drug Development
Fremont, CA site
Fremont, CA site
CIA Reporting Requirements
CIA Reporting Requirements
Brigitte Fuhr
Our data transformation
Funding Opportunities
Funding Opportunities
Our Innovation Strategy
Our innovation strategy focuses on developing a deep understanding of disease, identifying relevant disease mechanisms and using adequate therapeutic modalities to address them